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The effect of substances extracted from Toona sinensis leaves with 50% alcohol solution on
lipolysis was investigated in cultured 3T3-L1 differentiated adipocytes. The amount of
glycerol released from cells into culture medium was used to measure lipolysis activity.
Glycerol release was increased by Toona sinensis leaf extract in a dose-dependent and time-
dependent manner. Following treatment of 3T3-L1 adipocyte cells with various
concentrations of Toona sinensis leaf extract (0.001, 0.01, and 0.1 mg/mL) for 6 hours, the
amounts of glycerol released from 3T3-L1 cells increased from a control value of
99 nmol/mg protein to 127, 144, and 154 nmol/mg protein, respectively. The lipolytic effect
of Toona sinensis leaf extract was not inhibited by pretreatment of cells with cycloheximide,
econazole, baicalein, or indomethacin. However, the lipolytic activity induced by Toona
sinensis leaf extract was diminished by dibutyryl cyclic adenosine-5’-monophosphate
(dibutyryl cAMP) and the protein kinase C inhibitor calphostin C. These results indicate
that the lipolytic effect induced by Toona sinensis leaf substances may be involved in the
protein kinase C pathway and may be down-regulated by cAMP.
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Obesity is an increasingly prevalent and important
health problem. The search for anti-obesity agents has
become one of the most exciting areas in drug
discovery. It is hoped that lowering body weight will
reduce morbidity and mortality in the obese. Many
new substances, such as β3-adrenergic agonists [1]
and sibutramine, a centrally acting inhibitor of
noradrenaline and serotonin reuptake that decreases
caloric intake and increases energy expenditure, are
currently being investigated for their usefulness in the
pharmacotherapy of obesity [2]. Recently, common
beverages such as oolong tea have been reported to
possess anti-obesity and hypolipidemic effects; a wa-
ter extract of oolong tea enhances noradrenaline-
induced lipolysis [3]. Thus, it is helpful to look for
more new health foods for obese people.
Toona sinensis is an upland tree that is widely
distributed throughout Southeast Asia. Its leaves have
been used as a vegetable in China and Malaysia for a
long time [4]. We are not sure if Toona sinensis leaves
possess an anti-obesity effect. In the present study, we
evaluated the effects of Toona sinensis leaf extract on
lipolysis in cultured 3T3-L1 adipocytes. Our objective
was to find more anti-obesity agents.
MATERIALS AND METHODS
Materials
Dexamethasone, 3-isobutyl-1-methylxanthine (IBMX),
bovine serum albumin (BSA, fatty acid-free), adenosine-
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5’-triphosphate (ATP), phosphoenolpyruvate (PEP),
reduced nicotinamide adenine dinucleotide (NADH),
pyruvate kinase, lactate dehydrogenase, isoproterenol,
dibutyryl cyclic adenosine-5’-monophosphate (di-
butyryl cAMP), calphostin C, cycloheximide, econ-
azole, baicalein, and indomethacin were obtained from
Sigma Chemicals Co. (St. Louis, MO, USA). Other
drugs were obtained from Merck (E. Merck, Darmstadt,
Germany).
Cell culture
3T3-L1 cells, obtained from American Type Culture
Collection (ATCC, Rockville, MD, USA), were grown
in culture plates containing Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10%
heat-inactivated fetal bovine serum (Gibco, Grand
Island, NY, USA), 3.8 mM L-glutamine, and 50 µg/mL
gentamicin. The cultures were kept at 37°C in a
humidified chamber with 10% CO2. The medium was
changed every 2 or 3 days.
Differentiation of 3T3-L1 cells to
adipocytes
3T3-L1 pre-adipocytes were differentiated to
adipocytes as described previously by Hong et al [5].
Briefly, 2 days after confluence (Day 0), the medium
was removed and fresh medium containing 0.5 mM
IBMX and 0.25 mM dexamethasone was added. After
another 3 days, the medium was replaced with fresh
culture medium and the cultures were maintained as
described above. By Day 8, more than 90% of the cells
had differentiated into rounded cells with lipid
droplets.
Preparation of leaf extract
Substances were extracted from Toona sinensis leaves
by boiling in 50% v/v alcohol/water for 3 hours.
Following centrifugation at 2,000g for 10 minutes, the
extracted substances were lyophilized.
Measurement of lipolysis
Lipolytic activity was measured by assaying glycerol
released from cells into incubation buffer. Briefly, on
days 8 to 12, the medium was removed and the differ-
entiated adipocytes were incubated for 10 minutes in
serum-free medium with 1% BSA and Krebs-Ringer
phosphate (KRP) buffer (128 mM NaCl, 4.7 mM KCl,
1.25 mM CaCl2, 1.35 mM MgSO4, and 10 mM disodium
hydrogen phosphate [Na2HPO4] pH 7.4) containing
1 U/mL adenosine deaminase. Various concentrations
of Toona sinensis leaf extract in KRP buffer at concen-
trations of 0.001, 0.01, and 0.1 mg/mL were then
added to cells for 1, 3, and 6 hours. The incubation
mixture was aspirated and used to assay glycerol. In
agonist  and antagonist  experiments ,  10 -5 M
isoproterenol, 0.1 mM dibutyryl cAMP, 5.6 × 10-8 M
calphostin, 10-5 M cycloheximide, 5 × 10-5 M econazole,
5 × 10-5 M baicalein, or 5 × 10-5 M indomethacin was
added to cells 30 minutes before the addition of
0.01 mg/mL Toona sinensis leaf extract.
Glycerol assay
Glycerol was assayed enzymatically as described
previously [5]. The glycerol assay reagent contained
5 mM MgSO4, 0.9 mM ATP, 0.9 mM PEP, 6 U pyruvate
kinase, 2 U lactate dehydrogenase, and NADH to a
final absorbance at 340 nm of 0.9 to 1.0 in potassium
phosphate buffer, pH 7.0. The decrease in absorbance
at 340 nm was proportional to the concentration of
glycerol.
Statistical analysis
Overall significant differences between groups were
determined using one-way ANOVA. The least
significant difference was used to determine significant
differences between individual samples. Values were
considered to be significantly different from the control
if p was less than 0.05.
RESULTS
The control value for basal release of glycerol was
99 ±  7 nmol/mg protein. Following incubation with
Toona sinensis leaf extract 0.001, 0.01, and 0.1 mg/mL for
6 hours, cultured 3T3-L1 adipocytes released significantly
more glycerol: 127 ±  8, 144 ± 6, and 154 ±  9 nmol/mg
protein, respectively (Figure 1). The effect was dose-
dependent; glycerol release was 128%, 145%, and
156% of the control value. The lipolytic effect induced by
Toona sinensis leaf extract was also time-dependent.
Following incubation with 0.01 mg/mL of leaf extract
for 1, 3, and 6 hours, cultured 3T3-L1 adipocytes released
significantly more glycerol: 102 ±  9 nmol/mg protein
at baseline was increased to 124 ±  10, 136 ±  11, and
145 ± 9 nmol/mg protein (Figure 2). In the presence of
10-5 M isoproterenol for 30 minutes, glycerol release
increased to 155 ±  9 nmol/mg protein, 151% of the
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control value (Figure 3). A combination of 0.01 mg/mL
Toona sinensis leaf extract and isoproterenol changed
glycerol release to 140 ± 6 nmol/mg protein (Figure 3).
Pretreatment of cells with 0.1 mM dibutyryl cAMP for
30 minutes followed by incubation with 0.01 mg/mL
Toona sinensis leaf extract for 6 hours significantly
inhibited glycerol release to 107 ±  9 nmol/mg protein
(Figure 3). Similarly, pretreatment of cells with a protein
kinase C inhibitor (5.6 × 10-8 M calphostin C) also inhibited
Toona sinensis leaf extract-induced cellular lipolytic effects
(Figure 3).
Various other compounds such as the protein syn-
thesis inhibitor cycloheximide (10-5 M), the cytochrome
P-450 inhibitor econazole (5 × 10-5 M), the lipoxidase
inhibitor baicalein (5 × 10-5 M), and the cyclooxygenase
inhibitor indomethacin (5 × 10-5 M) failed to diminish
the Toona sinensis leaf extract-induced lipolytic effect
(Figure 4).
Figure 1. Dose-dependent effects of substances extracted from
Toona sinensis (TS) leaves on lipolysis in 3T3-L1 adipocytes.
Differentiated 3T3-L1 adipocytes were incubated with various
concentrations of extract for 6 hours and lipolysis was measured
by glycerol release from cells into culture medium. Values are
mean ±  standard error from three experiments with triplicate
determination. *p < 0.05 compared with control (n = 9).
Figure 2. Time-dependent effects of substances extracted from
Toona sinensis (TS) leaves on lipolysis in 3T3-L1 adipocytes.
Differentiated 3T3-L1 adipocytes were incubated in the presence
of 0.01 mg/mL Toona sinensis leaf extract for 1, 3, and 6 hours.
Lipolytic activity was measured from the amount of glycerol in
the culture medium. Values are mean ± standard error from three
experiments with triplicate determination. *p < 0.05 compared
with control (n = 9).
Figure 3. Effects of isoproterenol, calphostin C, and dibutyryl
cAMP on Toona sinensis (TS) leaf extract-stimulated lipolysis
in 3T3-L1 adipocytes. Differentiated 3T3-L1 adipocytes were
pretreated with 10-5 M isoproterenol, 5.6 × 10-8 M calphostin C,
or 0.1 mM dibutyryl cAMP for 30 minutes and then incubated
with Toona sinensis leaf substances for 6 hours. Lipolytic activity
was measured from the amount of glycerol in the culture medium.
Values are mean ± standard error from three experiments with
triplicate determination. *p < 0.05 compared with control (n = 9).
†p < 0.05 when compared to TS (n = 9).
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DISCUSSION
The present study demonstrated that exposure to vari-
ous concentrations of Toona sinensis leaf extract sig-
nificantly enhanced lipolytic activity in 3T3-L1
adipocytes. Up to now, there are few data on the
lipolytic effects of Toona sinensis leaves on cultured
adipocytes in vitro. Our results show that the regula-
tory mechanism of Toona sinensis leaves on cellular
lipolysis may be mediated by the protein kinase C
pathway, because glycerol release is inhibited by the
addition of calphostin C, a protein kinase C inhibitor.
cAMP may down-regulate Toona sinensis leaf extract-
induced lipolysis. Although extracts from oolong tea
also possess potent lipolytic activity, the active sub-
stance was identified as caffeine [3]. The present study
showed that a combination of isoproterenol and Toona
sinensis leaf extract did not have an additional enhanc-
ing effect when compared to Toona sinensis alone.
Thus, the regulatory mechanism of the lipolytic effect
of Toona sinensis leaf extract may be similar to that of
isoproterenol.
Isoproterenol is a non-selective adrenergic agonist
that stimulates lipolysis activity. It is popularly used
as a lipolysis-stimulating agent in the study of
adipocyte function [6]. Compounds acting selectively
on the β3-adrenoceptor are promising tools to achieve
sustained stimulation of lipolysis and energy
expenditure [7]. However, isoproterenol has more
effective lipolytic activity than specific β3-adrenergic
agonists such as BRL37344 and CGP12177 in large
mammals [8,9]. Thus, isoproterenol was used as the
stimulating agent in this study.
Pretreatment of cells with cycloheximide failed to
inhibit the enhanced lipolysis seen with Toona sinensis
leaf extract, indicating that protein synthesis is not
required. Similarly, arachidonic acid metabolic
pathways such as the cytochrome P-450, lipoxidase,
and cyclooxygenase pathways may also not regulate
Toona sinensis leaf extract-induced lipolysis.
In summary, this study demonstrated that Toona
sinensis leaf extract induced lipolysis in 3T3-L1 adipocytes.
Our results suggest that components of Toona sinensis
leaves have potent lipolytic activity in vitro. Their roles
in anti-obesity effects in vivo need to be further explored.
Toona sinensis leaf extract may potentially be used as an
anti-obesity agent in the future.
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